Code Vein 2 update 1.004 is out on all platforms and this applies balance adjustments. Two more updates are planned in March 2026t.
Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results